[Effects of interleukin-2 and lymphokine-activated killer cells on cell cultures and on transplanted tumors (nude mouse) of human pancreatic carcinomas].
D000818:Animals; D002277:Carcinoma / Q000628:therapy*; D004353:Drug Evaluation, Preclinical; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000276:immunology*; D008213:Lymphocyte Activation / Q000187:drug effects*; D008222:Lymphokines / Q000627:therapeutic use*; D051379:Mice; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D010190:Pancreatic Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins / Q000627:therapeutic use; D014407:Tumor Cells, Cultured
D007376:Interleukin-2; D008222:Lymphokines; D011994:Recombinant Proteins
Effekte von Interleukin-2 und Lymphokin-aktivierten Killerzellen auf Zellkulturen sowie Transplantattumoren (Nacktmaus) humaner Pankreaskarzinome.